Showing 411-420 of 3100 results for "".
Embracing Change: Father-Son Dermatologists Reflect on Their Decades of Experience
https://practicaldermatology.com/topics/general-topics/embracing-change-father-son-dermatologists-reflect-on-their-decades-of-experience/24023/With Kenneth Beer, MD, and Jacob I. Beer, MDBy Heidi SpleteOptimizing Patient Experience With Photodynamic Therapy
https://practicaldermatology.com/issues/supplements/optimizing-patient-experience-with-photodynamic-therapy/23972/As diagnoses of actinic keratosis rise, so has access to photodynamic therapy—making clear, compassionate communication a critical component of overall patient experience.Physician Spotlight: Sue Ellen Cox, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-sue-ellen-cox-md/23966/The Complex and Heterogeneous Pathophysiology of Atopic Dermatitis: Many Facets of Disease
https://practicaldermatology.com/topics/atopic-dermatitis/the-complex-and-heterogeneous-pathophysiology-of-atopic-dermatitis-many-facets-of-disease/23912/Erythema Multiforme Major Due to Fluconazole: A Case Report
https://practicaldermatology.com/youngmd-connect/resident-resource-center/erythema-multiforme-major-due-to-fluconazole-a-case-report/23887/DermWireTV: Dupixent for Kids; Epsolay Launch; Scleroderma Awareness; Chicago Derms Celebrate Diversity
https://practicaldermatology.com/topics/practice-management/dermwiretv-dupixent-for-kids-epsolay-launch-scleroderma-awareness-chicago-derms-celebrate-diversity/20100/Epsolay (benzoyl peroxide 5%) Cream from Galderma is now available for the topical treatment of rosacea. It was developed by Sol-Gel. Dupixent from Sanofi and Regeneron is now the only biologic medicine FDA approved for use from infancy through adulthood for the management of atopic dermatitis. JuneNew in My Practice: OTC Skincare/New Products
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-skincarenew-products/23704/Hidradenitis Suppurativa: Seeking More Pieces to the Puzzle
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-seeking-more-pieces-to-the-puzzle/23669/Evidence suggests that integrated approaches to care may yield best results for many patients.The Role for Rinvoq in AD Care
https://practicaldermatology.com/topics/atopic-dermatitis/the-role-for-rinvoq-in-ad-care/23663/One of the first oral JAK inhibitors approved in dermatology expands options for moderate to severe AD.Women in Dermatology: Iris Rubin, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-iris-rubin-md/23589/